LC
NUVA

Lindbrook Capital’s NuVasive, Inc. NUVA Stock Holding History

Lindbrook Capital’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-105
Closed -$4.33K – 2950
2022
Q4 		$4.33K Buy
105
+86
+453% +$3.48K ﹤0.01% 1896
2022
Q3 		$1K Sell
19
-303
-94% -$14.7K ﹤0.01% 2571
2022
Q2 		$16K Buy
322
+294
+1,050% +$15.8K ﹤0.01% 1075
2022
Q1 		$2K Buy
+28
New +$1.49K ﹤0.01% 2126
2020
Q2 		– Sell
-21
Closed -$1K – 1927
2020
Q1 		$1K Buy
+21
New +$1.41K ﹤0.01% 1621

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Lindbrook Capital's NUVA Position: Q1 2023 in Review

Lindbrook Capital sold out of NuVasive, Inc. (NUVA) in Q1 2023, closing a stake of 105 shares — an estimated $4.33K sold.

Lindbrook Capital first reported a position in NUVA in Q1 2020 and held it in 5 quarters. The position peaked at $16K in Q2 2022. 241 funds tracked by Wall St. Rank hold NUVA as of Q1 2023.

  • Lindbrook Capital reported no remaining NuVasive, Inc. position as of Q1 2023 after selling out during the quarter.
  • Lindbrook Capital sold 105 NuVasive, Inc. shares in Q1 2023, an estimated $4.33K.
  • Lindbrook Capital first reported a position in NuVasive, Inc. in Q1 2020 and held it in 5 quarters.
  • Lindbrook Capital's NuVasive, Inc. position peaked at $16K in Q2 2022.
  • 241 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2023.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.